Featured Research

from universities, journals, and other organizations

Every five minutes someone dies from a blood clot or deep vein thrombosis

Date:
March 5, 2011
Source:
Vascular Disease Foundation
Summary:
Each year between 100,000-180,000 Americans die as the result of pulmonary embolism, a complication from blood clots in the lungs. The Vascular Disease Foundation urges Americans, especially women, to learn about the risks of venous blood clots to help prevent these deaths. While men and women are at equal risk, the risk for deep vein thrombosis, or blood clots, varies depending on where a woman is in her lifecycle, her hormone levels, and if she has a family history of clotting disorders.

Each year between 100,000-180,000 Americans die as the result of pulmonary embolism, a complication from blood clots in the lungs. The Vascular Disease Foundation urges Americans, especially women, to learn about the risks of venous blood clots to help prevent these deaths. While men and women are at equal risk, the risk for deep vein thrombosis, or blood clots, varies depending on where a woman is in her lifecycle, her hormone levels, and if she has a family history of clotting disorders.

DVT occurs when a blood clot forms in the deep veins, usually of the pelvis or leg. DVT can be dangerous in two ways. First, DVT can be fatal if a blood clot breaks free from the leg veins and travels through the heart and lodges in the lung arteries. This complication, called pulmonary embolism (PE), causes between 100,000 and 180,000 deaths per year in the United States. Second, because blood clots can permanently damage the veins, as many as half of DVT survivors can experience long-term leg pain, heaviness and swelling that can progress to difficulty in walking, changes in skin color and open leg sores (known as ulcers). This condition, called post-thrombotic syndrome (PTS) or "chronic venous insufficiency," can significantly impair quality of life.

Certain individuals may be at greater risk for developing DVT, but it can occur in almost anyone. Risk factors or triggering events that are more likely to affect women include pregnancy and the six to eight weeks after giving birth, the use of birth control pills or postmenopausal hormone replacement therapy, cancer and its treatment, and major surgery.

Anyone may be at risk for DVT but the more risk factors you have, the greater your chances are of developing it. Knowing your risk factors gives you the chance to do something about it:

  • Hospitalization for a medical illness or any illness
  • Recent major surgery (especially orthopedic surgery) or injury or trauma
  • Personal history of a clotting disorder or previous DVT
  • Increasing age
  • Cancer and their treatments
  • Family history of DVT
  • Extended bed rest
  • Obesity
  • Smoking
  • Prolonged sitting when traveling (longer than 6 to 8 hours)

DVT and PE should be considered emergencies that require immediate care if any of the following symptoms are present:

Symptoms of Possible DVT:

  • Recent swelling of one leg Unexplained pain or tenderness of one leg Change in skin color or skin is hot to the touch

Symptoms of Possible PE:

  • Recent or sudden shortness of breath Sharp chest pain, especially when breathing in Coughing up blood or sudden collapse

"Every year, more people die from preventable blood clots than from breast cancer, AIDS and traffic accidents combined," said Dr. Samuel Goldhaber, Chairman of the Venous Disease Coalition. "It is so important to raise awareness about DVT and PE because although blood clots are common, few Americans have sufficient knowledge about blood clots and how to prevent them."


Story Source:

The above story is based on materials provided by Vascular Disease Foundation. Note: Materials may be edited for content and length.


Cite This Page:

Vascular Disease Foundation. "Every five minutes someone dies from a blood clot or deep vein thrombosis." ScienceDaily. ScienceDaily, 5 March 2011. <www.sciencedaily.com/releases/2011/03/110305105233.htm>.
Vascular Disease Foundation. (2011, March 5). Every five minutes someone dies from a blood clot or deep vein thrombosis. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/03/110305105233.htm
Vascular Disease Foundation. "Every five minutes someone dies from a blood clot or deep vein thrombosis." ScienceDaily. www.sciencedaily.com/releases/2011/03/110305105233.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins